Pharming Group (PHGUF) Stock Statistics & Valuation Metrics

Pharming Group has a market cap or net worth of $634.45M. The enterprise value is ―.

Pharming Group has 680,308,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharming Group’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -3.34%.

The current PE Ratio of Pharming Group is -59.89. Pharming Group’s PEG ratio is -1.36.

In the last 12 months, Pharming Group had revenue of 286.89M and earned -10.64M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -3.78M and capital expenditures -795.54K, giving a free cash flow of -4.58M billion.

Pharming Group pays an annual dividend of ―, resulting in a dividend yield of ―

Pharming Group upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.

Pharming Group as a current ratio of 3.78, with Debt / Equity ratio of 50.81%

In the past 12 months, Pharming Group has paid 2.43M in taxes.

Pharming Group EV to EBITDA ratio is 96.36, with an EV/FCF ratio of -267.42.

Pharming Group has $167.89M in cash and marketable securities with $112.31M in debt, giving a net cash position of -$55.58M billion.

Gross margin is 88.09%, with operating margin of -2.90%, and net profit margin of -3.71%.

The average price target for Pharming Group is $2.24, which is 11.43% higher than the current price. The consensus rating is Moderate Buy